Full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration

被引：0
|
作者：
Lee, Sang Hyeok [1 ]
Lee, Mee Yon [1 ]
机构：
[1] Catholic Univ Korea, Coll Med, Dept Ophthalmol, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2025年 / 35卷 / 01期
关键词：
Macular hole; anti-VEGF; brolucizumab; RETINAL-PIGMENT EPITHELIUM; RANIBIZUMAB; DETACHMENT;
D O I：
10.1177/11206721241286708
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
Purpose To describe a case of full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration, which has not been reported to date.Case description A 65-year-old male patient received brolucizumab intravitreal injection therapy for neovascular macular degeneration of the right eye. He received multiple intravitreal anti-VEGF injections on a pro re nata regimen and developed a full thickness macular hole.Outcome Surgical treatment was performed with pars plana vitrectomy of the right eye. Full thickness macular hole was successfully treated.Conclusion Although a full thickness macular hole following intravitreal brolucizumab injection is an uncommon complication, it requires caution.
引用
收藏
页码：NP16 / NP19
页数：4
相关论文
共 50 条
  • [21] Comment on “Intravitreal conbercept injection for neovascular age-related macular degeneration”
    Dan C?lug?ru
    Mihai C?lug?ru
    International Journal of Ophthalmology, 2020, (02) : 362 - 364
  • [22] Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration
    Yeo Jue Byun
    Sung Jun Lee
    Hyoung Jun Koh
    Japanese Journal of Ophthalmology, 2010, 54 : 571 - 577
  • [23] INTRAOCULAR INFLAMMATION INCIDENCE AFTER INTRAVITREAL BROLUCIZUMAB INJECTION FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Pakravan, Parastou
    Patel, Veshesh
    Lai, James
    Shaheen, Abdulla
    Kalahasty, Karthik
    Reyes-Capo, Daniela
    Chau, Viet
    Rosenfeld, Philip
    Haddock, Luis
    Schwartz, Stephen
    Smiddy, William
    Kovach, Jaclyn
    Sridhar, Jayanth
    Flynn, Harry
    Albini, Thomas
    Yannuzzi, Nicolas
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2023, 43 (10): : 1717 - 1722
  • [24] Visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration
    Tan, C. S. H.
    EYE, 2011, 25 (10) : 1374 - 1374
  • [25] Intraocular Inflammation Secondary to Intravitreal Brolucizumab Injection for Neovascular Age-Related Macular Degeneration in a Patient with Cognitive Impairment
    Ueji, Natsuki
    Mase, Yoko
    Kubo, Akiko
    Matsubara, Hisashi
    Chujo, Shinichiro
    Matsui, Yoshitsugu
    Kondo, Mineo
    MEDICINA-LITHUANIA, 2023, 59 (10):
  • [26] Visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration
    C S H Tan
    Eye, 2011, 25 : 1374 - 1374
  • [27] Predictors of Response After Intravitreal Bevacizumab Injection for Neovascular Age-Related Macular Degeneration
    Byun, Yeo Jue
    Lee, Sung Jun
    Koh, Hyoung Jun
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2010, 54 (06) : 571 - 577
  • [28] Brolucizumab for Neovascular Age-Related Macular Degeneration (BEL Study)
    Van Cleemput, Liesbeth
    Peeters, Freya
    Jacob, Julie
    CLINICAL OPHTHALMOLOGY, 2023, 17 : 1077 - 1085
  • [29] Brolucizumab: an evolution in treatment for neovascular age-related macular degeneration
    Ong, Ee Lin
    Spooner, Kimberly
    Hong, Thomas
    Chang, Andrew
    EXPERT REVIEW OF OPHTHALMOLOGY, 2020, 15 (02) : 71 - 81
  • [30] Changes in ocular blood flow in patients with neovascular age-related macular degeneration after intravitreal injection of ranibizumab biosimilar and brolucizumab
    Takizawa, Hiroki
    Yasuda, Masayuki
    Hoshi, Keisuke
    Okabe, Tatsu
    Kunikata, Hiroshi
    Nakazawa, Toru
    INTERNATIONAL OPHTHALMOLOGY, 2024, 44 (01)
12345